1. Home
  2. KOSS vs AFMD Comparison

KOSS vs AFMD Comparison

Compare KOSS & AFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KOSS
  • AFMD
  • Stock Information
  • Founded
  • KOSS 1953
  • AFMD 2000
  • Country
  • KOSS United States
  • AFMD Germany
  • Employees
  • KOSS N/A
  • AFMD N/A
  • Industry
  • KOSS Consumer Electronics/Appliances
  • AFMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • KOSS Consumer Staples
  • AFMD Health Care
  • Exchange
  • KOSS Nasdaq
  • AFMD Nasdaq
  • Market Cap
  • KOSS 63.0M
  • AFMD 53.3M
  • IPO Year
  • KOSS N/A
  • AFMD 2014
  • Fundamental
  • Price
  • KOSS $7.34
  • AFMD $3.36
  • Analyst Decision
  • KOSS
  • AFMD Strong Buy
  • Analyst Count
  • KOSS 0
  • AFMD 5
  • Target Price
  • KOSS N/A
  • AFMD $16.25
  • AVG Volume (30 Days)
  • KOSS 183.8K
  • AFMD 80.0K
  • Earning Date
  • KOSS 11-08-2024
  • AFMD 11-12-2024
  • Dividend Yield
  • KOSS N/A
  • AFMD N/A
  • EPS Growth
  • KOSS N/A
  • AFMD N/A
  • EPS
  • KOSS N/A
  • AFMD N/A
  • Revenue
  • KOSS $12,265,069.00
  • AFMD $7,959,927.00
  • Revenue This Year
  • KOSS N/A
  • AFMD N/A
  • Revenue Next Year
  • KOSS N/A
  • AFMD $48.98
  • P/E Ratio
  • KOSS N/A
  • AFMD N/A
  • Revenue Growth
  • KOSS N/A
  • AFMD N/A
  • 52 Week Low
  • KOSS $2.27
  • AFMD $2.92
  • 52 Week High
  • KOSS $18.73
  • AFMD $8.95
  • Technical
  • Relative Strength Index (RSI)
  • KOSS 50.17
  • AFMD 44.84
  • Support Level
  • KOSS $7.00
  • AFMD $3.28
  • Resistance Level
  • KOSS $7.83
  • AFMD $3.51
  • Average True Range (ATR)
  • KOSS 0.44
  • AFMD 0.17
  • MACD
  • KOSS -0.01
  • AFMD 0.04
  • Stochastic Oscillator
  • KOSS 32.26
  • AFMD 55.79

About KOSS Koss Corporation

Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-cancelling headphones. The majority of the firm's revenue is derived from sales of stereo headphones.

About AFMD Affimed N.V.

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.

Share on Social Networks: